Drug
Malic Acid
Malic Acid is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
1
33%
Ph early_phase_1
1
33%
Ph not_applicable
1
33%
Phase Distribution
1
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (33.3%)
Phase 21 (33.3%)
N/A1 (33.3%)
Trials by Status
unknown133%
completed133%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingearly_phase_1
Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
NCT07325123
unknownnot_applicable
Malic Acid in Treatment of Xerostomia
NCT04756986
completedphase_2
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001
Clinical Trials (3)
Showing 3 of 3 trials
NCT07325123Early Phase 1
Malic Acid Supplementation Combined With Immunotherapy in Patients With Solid Tumors
NCT04756986Not Applicable
Malic Acid in Treatment of Xerostomia
NCT01652001Phase 2
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3